Avenue Therapeutics, Inc. (ATXI)

Avenue Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	3	2	6	17	100	160
Market Cap Growth	-5.73%	-61.48%	-67.39%	-82.96%	-37.70%	177.80%
Enterprise Value	0	0	-1	13	97	151
PE Ratio	-	-0.21	-1.56	-4.55	-19.35	-6.17
PB Ratio	1.14	1.35	1.42	4.92	42.24	23.52
P/FCF Ratio	-0.59	-0.23	-0.73	-4.53	-17.75	-6.09
P/OCF Ratio	-0.59	-0.23	-0.73	-4.53	-21.60	-6.09
EV/EBITDA Ratio	-0.46	-0.03	0.33	-3.54	-18.74	-5.84
EV/EBIT Ratio	-0.46	-0.03	0.33	-3.54	-18.74	-5.84
EV/FCF Ratio	-0.30	-0.04	0.15	-3.52	-17.20	-5.76
Quick Ratio	2.26	1.49	1.87	7.57	3.53	4.13
Current Ratio	2.34	1.55	1.91	7.78	3.66	4.22
Return on Equity (ROE)	628.80%	468.70%	-252.70%	-276.00%	-133.20%	-195.50%
Return on Assets (ROA)	-392.00%	-333.00%	-136.90%	-191.80%	-105.00%	-151.90%
Return on Capital (ROIC)	-416.71%	-919.09%	-205.97%	-108.32%	-220.98%	-386.25%
Earnings Yield	-221.20%	-486.53%	-64.15%	-21.97%	-5.17%	-16.20%
FCF Yield	-338.78%	-443.11%	-137.19%	-22.08%	-5.63%	-16.42%
Buyback Yield / Dilution	-657.47%	-384.72%	-92.83%	-2.97%	-4.99%	-53.54%
Total Shareholder Return	-657.47%	-384.72%	-92.83%	-2.97%	-4.99%	-53.54%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).